# Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19

> **NCT04776044** · PHASE2 · TERMINATED · sponsor: **Atriva Therapeutics GmbH** · enrollment: 133 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** ATR-002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04776044
- **Lead sponsor:** Atriva Therapeutics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-12
- **Primary completion:** 2022-06-06
- **Final completion:** 2022-08-09
- **Target enrollment:** 133 (ACTUAL)
- **Why stopped:** general circumstances around COVID-19 and current availability of hospitalized patients
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776044, "Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04776044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*